We use cookies for a better user experience. Read our Privacy Policy

I Agree

Acute Ischemic Stroke Diagnosis and Treatment Market

Acute Ischemic Stroke Diagnosis and Treatment Market (By Diagnostics Type - CT, MRI, Ultrasound, Cerebral Angiography, Nuclear Imaging and Others By Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Acute ischemic stroke can be defined as loss of function in certain parts of brain due to lack or disturbance in the blood supply to the brain. This is usually caused by atherosclerosis plaques blocking blood vessels, narrowing of blood vessels, or blood clots closing off blood supply to or from arteries feeding the brain. Technological advancements in surgical devices coupled with rising prevalence of acute ischemia stroke cases collectively accentuates the global demand of surgical procedures in acute stroke treatment. Similarly, aging population, increased demand for minimally invasive procedures and rise in healthcare spending has triggered the growth of this segment market. However, excessive usage of medication for the treatment of ischemic stroke is anticipated to hinder the global market growth of surgery for acute stroke. The global acute ischemic stroke diagnosis and treatment market was valued at USD 1,225.0 million in 2013 and is expected to grow at a CAGR of 6.3% from 2014 to 2020, to reach an estimated value of USD 1,869.7 million by 2020.  

The global market for acute ischemic stroke diagnosis and treatment is segmented based on diagnostics type as CT, MRI, ultrasound, cerebral angiography, nuclear imaging and others. In 2013, CT segment accounted for the largest market share of the global acute ischemic stroke diagnosis and treatment market owing to efficient and effective detection, easy availability and strong demand of CT in the global market. Moreover, MRI is expected to grow at the highest CAGR compared with all diagnostic device types during the forecast period due to its increasing popularity. 

In addition, the global market for acute ischemic stroke diagnosis and treatment is segmented based on surgery types as carotid endarterectomy, angioplasty and endovascular mechanical thrombectony. In 2013, carotid endarterectomy accounted for the largest market share and is expected to grow at the highest CAGR in the global acute ischemic stroke surgical treatment market owing to high success rate, easy availability and short treatment duration.  

Geographically, North America was the largest market for acute ischemic stroke diagnosis and treatment in 2013, accounting for the largest share of the acute ischemic stroke diagnosis and treatment market and is expected to grow at a highest CAGR from 2014 to 2020. The acute ischemic stroke diagnosis and treatment market in North America witnessed significant growth due to increasing demand of ischemic stroke products and technological innovations. Moreover, favorable government initiatives have also supported the growth of the acute ischemic stroke diagnosis and treatment market in this region. Europe was the second largest market of the global market in 2013. Rising geriatric population in European Union is one of the major market drivers in this region as geriatric group are more prone to suffer from stroke. 

Asia-Pacific was observed to be a promising market for acute ischemic stroke diagnosis and treatment market during the study period owing to the increasing prevalence of ischemic stroke cases in this region. This region accounted for the third largest share of the global market in 2013 and is estimated to grow at the highest CAGR from 2014 to 2020. Manufacturer of acute ischemic stroke diagnosis and treatment products are expanding their operations in Asian countries (India, China, Japan and South Korea) as these economies hold immense potential for acute ischemic stroke diagnosis and treatment products. For instance, Medtronic Inc, in 2011, established the R&D Shanghai innovation center in China. This facility was established to support further localization in this region. This has helped the company to promote its neurovascular products in emerging countries. Major players operating in the global acute ischemic stroke diagnosis and treatment market includes Covidien plc, Johnson and Johnson, Stryker Corporation and Abbott Laboratories. 

Acute Ischemic Stroke Diagnosis and Treatment Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Assumptions
1.4 List of Abbreviations
 
Chapter 2 Executive Summary
2.1 Overview
2.2 Market Snapshot: Global Acute Ischemic Stroke Diagnosis and Treatment Market (2013 & 2020)
2.3 Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Types , 2013 (USD Million)
2.4 Comparative Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 and 2020 (Value %)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Event Impact Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
3.3 Market Drivers
      3.3.1 Rising number of acute stroke patients aiding the growth of diagnosis and treatment market
      3.3.2 Technological innovations in diagnostic and surgical devices boosts market growth
3.4 Restraints
      3.4.1 Alternative treatments and high cost are posing a threat for the growth of the market
3.5 Opportunities
      3.5.1 Huge potential patient in Asia-Pacific creates opportunity for acute ischemic stroke product developers record high growth in revenue
3.6 Value Chain Analysis
3.7 Porter’s Five Force Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
      3.7.1 Bargaining power of suppliers
      3.7.2 Bargaining power of buyers
      3.7.3 Threat of new entrants
      3.7.4 Threat of substitutes
      3.7.5 Competitive rivalry
3.8 Market Attractiveness Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
3.9 Competitive Landscape
      3.9.1 Market Share Analysis by Key Players, 2013 (Value %)
 
Chapter 4 Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type
4.1 Overview
      4.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Diagnostic Types, 2012 – 2020 (USD Million)
4.2 Computed Tomography
      4.2.1 Global Computed Tomography Market Revenue, 2012 – 2020 (USD Million)
4.3 Magnetic Resonance Imaging
      4.3.1 Global Magnetic Resonance Imaging Market Revenue, 2012 – 2020 (USD Million)
4.4 Ultrasound
      4.4.1 Global Ultrasound Market Revenue, 2012 – 2020 (USD Million)
4.5 Cerebral angiography
      4.5.1 Global Cerebral Angiography Market Revenue, 2012 – 2020 (USD Million)
4.6 Nuclear Imaging
      4.6.1 Global Nuclear Imaging Market Revenue, 2012 – 2020 (USD Million)
4.7 Others
      4.7.1 Global Others Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 5 Acute Ischemic Stroke Diagnosis and Treatment Market by, Surgery Type
5.1 Overview
      5.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Surgery Type, 2012 – 2020 (USD Million)
5.2 Carotid Endarterectomy
      5.2.1 Global Carotid Endarterectomy Market Revenue, 2012 – 2020 (USD Million)
5.3 Angioplasty
      5.3.1 Global Angioplasty Market Revenue, 2012 – 2020 (USD Million)
5.4 Endovascular Mechanical Thrombectomy
      5.4.1 Global Endovascular Mechanical Thrombectomy Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 6 Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
6.1 Overview
      6.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Geography, 2012 – 2020 (USD Million)
6.2 North America
      6.2.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
6.3 Europe
      6.3.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
6.5 Rest of the World
      6.5.1 RoW Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 7 Recommendations
7.1 Rigorous research and development initiatives for innovative products
7.2 Investing in emerging economies
 
Chapter 8 Company Profiles
8.1 Abbott Laboratories
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Covidien plc
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 Johnson & Johnson (Cordis Corporation)
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 Penumbra, Inc.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Philips Healthcare
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 GE Healthcare
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 Hitachi, Ltd.
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 Siemens Healthcare
      8.8.1 Company Overview
      8.8.2 Financial overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 Stryker Corporation (Concentric Medical, Inc.)
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments
List of Tables
 
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Acute Ischemic Stroke Diagnosis and Treatment Market (2013 & 2020)
TABLE 3 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Diagnostic Types, 2012 – 2020 (USD Million)
TABLE 4 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Surgery Type, 2012 – 2020 (USD Million)
TABLE 5 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Geography, 2012 – 2020 (USD Million)

List of Figures

 

FIG. 1 Acute Ischemic Stroke Diagnosis and Treatment: Market Segmentation

FIG. 2 Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Types, 2013 (USD Million)

FIG. 3 Comparative Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 & 2020 (Value %)

FIG. 5 Porter’s Five Forces Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market

FIG. 6 Market Attractiveness Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 Value (%)

FIG. 7 Market Share Analysis: Acute Ischemic Stroke Diagnosis and Treatment Market, 2013 (Value %)

FIG. 8 Global Computed Tomography Market Revenue, 2012 – 2020 (USD Million)

FIG. 9 Global Magnetic Resonance Imaging Market Revenue, 2012 – 2020 (USD Million)

FIG. 10 Global Ultrasound Market Revenue, 2012 – 2020 (USD Million)

FIG. 11 Global Cerebral Angiography Market Revenue, 2012 – 2020 (USD Million)

FIG. 12 Global Nuclear Imaging Market Revenue, 2012 – 2020 (USD Million)

FIG. 13 Global Others Market Revenue, 2012 – 2020 (USD Million)

FIG. 14 Global Carotid Endarterectomy Market Revenue, 2012 – 2020 (USD Million)

FIG. 15 Global Angioplasty Market Revenue, 2012 – 2020 (USD Million)

FIG. 16 Global Endovascular Mechanical Thrombectomy Market Revenue, 2012 – 2020 (USD Million)

FIG. 17 North America Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)

FIG. 18 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)

FIG. 19 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)

FIG. 20 RoW Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)

FIG. 21 Abbott Laboratories: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 22 Covidien plc: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 23 Johnson & Johnson: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 24 Philips Healthcare: Annual Revenue,2011 – 2013 (USD Million)

FIG. 25 GE Healthcare: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 26 Hitachi, Ltd.: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 27 Siemens Healthcare: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 28 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

888

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved